MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
How They Work: One Hormone vs Three Orforglipron is a small-molecule, non-peptide GLP-1 receptor agonist
At $141/mo on the 6-month semaglutide plan (using the discount code policy-lab-50), youre getting the lowest prices on our list with the added benefit of one price for all dosages
MedLeanRX Blog Weight Loss Education & Insights Expert articles on GLP-1 medications, treatment expectations, and physician-guided weight loss care
The vagus nerve serves as a primary conduit, carrying signals in both directions
Changing your life takes more than willpowerit takes the right support